Exact Sciences has put down $190 million to buy testing laboratory PreventionGenetics, aiming to expand its diagnostics franchise into hereditary cancer screening.
PreventionGenetics offers more than 5,000 DNA tests, including germline and whole exome sequencing panels, to help users identify potential risks they may have inherited for developing cancer or other diseases.